Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics) - Image 1

£37.85

CRC Press Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)

Name: Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)
Brand: CRC Press
Price: 37.85 GBP
Availability: InStock

Reference

It has never been this cheap. We have no record of a lower price.

£38 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 51 days • 51 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 51 days • 1 price levels

Days at Price

Price Analysis

Most common price: £38 (51 days, 100.0%)

Price range: £38 - £38

Price levels: 1 different prices over 51 days

Description

Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity’s Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization. Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 1498761305
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Reference
Domain: Amazon UK
Release Date: 28 June 2019
Listed Since: 07 December 2017

Barcode

No barcode data available

CRC Press Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)

Phase I Oncology Drug Development

Assessing the Economic Value of Anticancer Therapies: 148 (Recent Results in Cancer Research, 148)

Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems

CRC Press Statistical Approaches in Oncology Clinical Development

Cancer Chemotherapy: Basic Science to the Clinic

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

Regulatory and Economic Aspects in Oncology: 213 (Recent Results in Cancer Research, 213)

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Springer Therapeutic Approaches in Cancer Treatment 185

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Handbook of Statistics in Clinical Oncology

The Bethesda Handbook of Clinical Oncology

Therapeutic Approaches in Cancer Treatment: 185 (Cancer Treatment and Research, 185)

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Handbook of Targeted Cancer Therapy and Immunotherapy

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Holland-Frei Cancer Medicine - Volume 1 and 2

Humana Combination Cancer Therapy: Modulators and Potentiators

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)